Growth Metrics

Bio-Techne (TECH) EBT (QoQ) (2009 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Bio-Techne 7.92 Bn 7.71 Bn 208.29 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 40.25%
Dec 31, 2025 5.82%
Sep 30, 2025 143.76%
Jun 30, 2025 -386.55%
Mar 31, 2025 -10.73%
Dec 31, 2024 6.73%
Sep 30, 2024 30.52%
Jun 30, 2024 -49.61%
Mar 31, 2024 82.96%
Dec 31, 2023 -32.63%
Sep 30, 2023 -43.89%
Jun 30, 2023 10.13%
Mar 31, 2023 20.72%
Dec 31, 2022 -35.95%
Sep 30, 2022 31.20%
Jun 30, 2022 14.95%
Mar 31, 2022 -20.20%
Dec 31, 2021 27.89%
Sep 30, 2021 248.42%
Jun 30, 2021 -200.10%
Mar 31, 2021 -19.54%
Dec 31, 2020 43.29%
Sep 30, 2020 -36.06%
Jun 30, 2020 31.40%
Mar 31, 2020 -68.85%
Dec 31, 2019 744.24%
Sep 30, 2019 -21.86%
Jun 30, 2019 -54.32%
Mar 31, 2019 129.14%
Dec 31, 2018 23.77%
Sep 30, 2018 169.55%
Jun 30, 2018 -201.22%
Mar 31, 2018 14.96%
Dec 31, 2017 -5.38%
Sep 30, 2017 -39.32%
Jun 30, 2017 21.54%
Mar 31, 2017 105.04%
Dec 31, 2016 -45.34%
Sep 30, 2016 166.06%
Jun 30, 2016 -75.42%
Mar 31, 2016 20.12%
Dec 31, 2015 11.07%
Sep 30, 2015 444.86%
Jun 30, 2015 -84.92%
Mar 31, 2015 -8.94%
Dec 31, 2014 23.02%
Sep 30, 2014 139.21%
Jun 30, 2014 -291.52%
Mar 31, 2014 27.20%
Dec 31, 2013 -8.66%
Sep 30, 2013 -2.72%
Jun 30, 2013 -8.33%
Mar 31, 2013 18.75%
Dec 31, 2012 -1.42%
Sep 30, 2012 -6.48%
Jun 30, 2012 -5.99%
Mar 31, 2012 14.08%
Dec 31, 2011 -6.49%
Sep 30, 2011 145.97%
Jun 30, 2011 -294.14%
Mar 31, 2011 20.47%
Dec 31, 2010 -3.29%
Sep 30, 2010 145.16%
Jun 30, 2010 -308.16%
Mar 31, 2010 12.92%
Dec 31, 2009 -7.58%